BIOGENA • Investment story • Direct digital investment

BIOGENA investment story

A family business becomes a health group. What began for BIOGENA as a family-run micronutrient company is today a health group with more than 120 million euros in revenue.

Since 2015, many investors have accompanied this journey through Invesdor. Since then, BIOGENA has carried out 16 financing rounds via Invesdor. In total, more than 17 million euros in growth capital flowed into the company. BIOGENA is now carrying out a share issue and preparing for a listing on the Direct Market Plus (Vienna MTF) of the Vienna Stock Exchange. This makes BIOGENA an example of direct digital investment in a real company that has developed step by step and is now entering the capital market.

Direct digital investment: the role of Invesdor investors

Between 2015 and 2022, BIOGENA carried out a total of 16 financing rounds via Invesdor. During this period, investors provided more than 17 million euros in growth capital through Invesdor.

This path is characterized by:

1

Long-term partnership

BIOGENA did not choose this form of financing only once, but repeatedly, adapted to each respective growth phase.

2

Direct participation for many instead of a few

Private and smaller professional investors were able to participate at an early stage, with amounts suited to their personal situation. Over the years, this created a broad circle of supporters.

3

Strong European roots

A significant share of the investments came from Germany, Austria and other European countries — the same markets in which BIOGENA is also gaining customers. Since 2015, around 2,100 investors have invested in BIOGENA through Invesdor. On average, investments amounted to around 7,300 euros per person. Depending on the round, the interest rates of the individual bonds ranged from 3.75% to 6.00% per year. All investments were repaid to investors on schedule and in full.

For many people in Germany, Austria and other European countries, BIOGENA therefore offered an opportunity to participate directly in a medium-sized health company and follow its development over several years.

What BIOGENA has achieved so far

The capital market prospectus for the current share issue describes BIOGENA’s starting position with clear figures. For the 2024/2025 financial year, the Biogena Group reports, among other things:

• group revenue of around 124.9 million euros
• historical EBITDA of around 19.1 million euros
• an EBITDA margin of around 15.3 percent
• group equity of around 298.9 million euros

BIOGENA offers more than 400 products and works with around 30,000 doctors and therapists. The company serves customers in around 70 countries and has more than half a million registered members in the BIOGENA Club. According to the prospectus, BIOGENA already has a production capacity built for revenues of around €500 million, which is currently only partially utilized. These figures and structures show an established company with audited financial statements, international reach and a clear focus on prevention and health.

Why the step onto the stock exchange is a logical one

Against this background, the planned step onto the stock exchange is a logical next step for BIOGENA. An IPO enables further equity capital for growth, for example for internationalization, product development, digitalization and new locations.

It creates additional visibility and trust in a regulated environment.

It enables a broader distribution of ownership, into which existing investors can also place themselves as part of their own decisions. For many years, BIOGENA relied on direct financing via Invesdor. This phase helped expand the production capacity, broaden the market and strengthen digital channels. The now planned listing on Direct Market Plus of the Vienna Stock Exchange adds the capital market level to this path.

Context for investors

What investors gain from this now

For people who have already financed BIOGENA through Invesdor, the current development is an important milestone. They can see that a family business has become a health group with revenue well above 120 million euros. All BIOGENA investments placed via Invesdor were repaid as agreed.

• The company has reached a stage where a stock exchange listing can be carried out.

For investors who are only now getting to know BIOGENA, a different perspective emerges: this is a company with a clear market position and tangible products.

• The development of recent years and the current situation are presented transparently in the prospectus.

In both cases, the share issue opens up the opportunity to assess whether and in what form participation in the next stage of the BIOGENA story fits into one’s own investment concept. All information on the current share issue, the use of proceeds and the risks can be found in the capital market prospectus and on BIOGENA’s information page.

Current share issue

Further information on the current BIOGENA share issue

All information on the current share issue, the documents and further details can be found directly on BIOGENA’s information page.

To the BIOGENA share issue

The link opens BIOGENA’s information page in a new tab.

Notes and risks

This text provides information about BIOGENA’s development and the role of Invesdor investors. It does not constitute investment advice and is not an invitation to buy or sell securities. Invesdor does not provide investment brokerage in this context.

The basis for an investment decision is exclusively the published capital market prospectus and the documents of the issuer. Investments in securities and corporate participations involve significant risks, including the complete loss of the capital invested.

The post How Direct Digital Investing can pave the way to the Stock Market first appeared on Invesdor - Blog.

In this interview, Invesdor’s real estate experts — Anna Hoos, Stefan Ertl and Christopher Müller — explain how the market has changed, where new opportunities are emerging, and what investors should pay attention to today.

How do you assess the current development of the real estate market from an investor perspective?

Stefan Ertl: We are coming out of a highly complex market phase that has already had noticeable economic effects, especially within the banking sector. Banks are financing projects much more cautiously today than they did a few years ago and are covering smaller portions of total project costs. At the same time, demand for real estate remains strong across many sectors. This creates a financing gap, as project developers now need to provide more equity to move projects forward.

What developments are currently shaping the real estate market?

Christopher Müller: The real estate market moves in cycles — and we are currently in one of those cycles. However, the current downturn and adjustment phase has been accelerated by an exceptional combination of external shocks: COVID-19, the war in Ukraine, the energy crisis, inflation, and rising interest rates all impacted the market within a short period of time. Even so, the overall market behavior still reflects patterns we know from traditional real estate cycles.

What makes this phase different is the structural transformation emerging from it. Higher financing costs, persistently elevated construction costs, increasing regulatory requirements, and growing political pressure around housing are leading to a new market equilibrium. The market that emerges from this period will look fundamentally different from the one before the crisis.

At the same time, housing remains one of the most urgent topics. Demand for residential space continues to significantly exceed supply. In Germany alone, the government is currently missing its annual target of 400,000 new homes by approximately 100,000 to 150,000 units, while a broader housing shortage of more than one million homes is being discussed. Housing and infrastructure therefore remain structural pillars within a market that is currently repositioning itself.

The post Real Estate as an Investment: Is Now the Right Time to Get Started? first appeared on Invesdor - Blog.

In recent years, some of the most significant value creations in global markets have happened before companies even reached the public stock exchange. Investors who gained early access to companies like Airbnb, Uber, or Snowflake often saw substantial valuation increases between late-stage private rounds and their eventual IPOs.

For example, Airbnb was valued at around $31 billion in private markets in 2017 and reached a market capitalisation of over $100 billion shortly after its IPO. Similarly, Snowflake became one of the largest software IPOs ever, delivering strong valuation uplifts from its final private funding rounds.

More recently, companies like OpenAI, Anthropic, and Oura have shown how quickly valuations in late-stage private markets can evolve – driven by technological breakthroughs, rapid adoption, and global market positioning.

At the same time, access to these opportunities has traditionally been limited to institutional investors, venture capital funds, and ultra-high-net-worth individuals.

Why is Invesdor offering Pre-IPO investments?

At Invesdor, we believe investors should be able to build diversified portfolios across the full company lifecycle. Invesdor already provides access to growth-stage startups and scale-ups through equity funding, as well as to more mature SMEs, renewable energy and real-estate investment opportunities via fixed-interest debt. Between these, there has traditionally been a gap.

Pre-IPO investments are designed to close this gap by offering investors access to late-stage companies that are already well-developed and often have a clear path toward an IPO or strategic exit within a few years.

The goal is to enable investors to participate in value creation from early growth all the way to the pre-IPO stage, while being transparent that these investments remain illiquid, high-risk, and should be considered as part of a diversified portfolio.

We are an impact-first investment platform. At the same time, we believe in expanding access to a broader range of opportunities, including pre-IPO investments. While the companies we currently have visibility on are not primarily impact- or ESG-focused, we will continue to monitor this space and aim to include more impact-aligned opportunities over time.

What is Pre-IPO investing? An introduction

Investing in companies before they go public has traditionally been reserved for institutional investors, venture capital funds, and ultra-high-net-worth individuals. However, access to these opportunities has gradually broadened, allowing a wider range of investors to participate in what is known as Pre-IPO investing.

In this article, we explain what Pre-IPO investing is, how it works in practice, and what investors should carefully consider before deciding to invest.

What does “Pre-IPO” mean?

A Pre-IPO investment refers to investing in a company while it is still privately held – meaning before its shares are listed and traded on a public stock exchange.

At this stage, companies are typically relatively mature. They often generate substantial revenue, have established business models, and are backed by experienced investors. In many cases, such companies are preparing for a potential exit such as an IPO or a strategic sale.

Typical characteristics of Pre-IPO companies include:

• A proven product or service with growing market traction
• Strong revenue growth and scaling operations
• Institutional investors already on the cap table
• A potential path toward an IPO or acquisition

These companies are often active in sectors driven by long-term trends such as technology, energy transition, or digital infrastructure, making them particularly relevant for forward-looking investors.

Why do investors consider Pre-IPO companies?

Investing in Pre-IPO companies can offer access to companies at a stage where significant growth potential still exists, while the business is already more developed than in early-stage venture investing.

Investors are typically attracted by a combination of strategic and financial considerations:

• Early access to growth – Invest in the potential return of a company before it enters public markets
• Potential valuation upside – Opportunity to benefit from future price increase at IPO or exit
• Diversification – Exposure to private markets alongside listed assets
• Innovation exposure – Access to some of the most innovative companies globally

At the same time, it is important to recognise that Pre-IPO investment opportunities are not directly comparable to listed equities. The expected investment horizon is longer and the risk associated with the investment product is higher.

How does Pre-IPO investing work in practice?

Unlike investing in publicly listed shares, Pre-IPO investments are usually structured indirectly through so-called derivatives, as direct access to company shares is often restricted.

In practice, the structure often works as follows:

• Investors subscribe to a financial instrument (e.g. a bond or participation structure)
• The financial instrument is constructed to follow the return of the target company
• The invested capital is pooled and deployed via special purpose vehicles (SPVs)
• These SPVs acquire shares in the target company
• Investors get financial exposure towards the performance of the target company

This means that investors do not hold shares in the target company directly but gain exposure to the return of the target company through a structured setup. While this structure enables access, it also comes with additional layers that need to be understood, including legal structure, fees, and governance.

Typical exit scenarios for Pre-IPO investments

Pre-IPO investments are by default long-term investments, where the return depends on a successful future exit event. The exit may be significantly delayed, occur later than anticipated, or not happen at all.

The most common exit routes include:

• Initial Public Offering (IPO) – The target company lists its shares on a stock exchange
• Mergers and Acquisitions (M&A) – The target company is acquired by another firm
• Secondary transactions – The shares of the target company are sold to other private investors

It is important to highlight that the timing and likelihood of an exit is uncertain. Even if a company has communicated IPO ambitions, market conditions or strategic decisions can delay or prevent such an outcome. In addition, lock-up periods after an IPO may restrict immediate liquidity.

Pre-IPO investments: understanding the key risks

Investing in Pre-IPO companies is associated with a higher level of risk compared to traditional listed equities, and a clear understanding of these risks is essential.

Key risk factors include:

• Total loss risk – The invested capital can be lost entirely
• Illiquidity – Capital is typically tied up for several years
• Structural complexity – Indirect investment structures add additional layers
• Valuation uncertainty – Private market pricing can change significantly
• External influences – Market conditions, regulation, and macroeconomic factors impact outcomes

In addition, investors should consider that fees, dilution effects, and currency fluctuations may further influence the final return and potentially reduce performance.

Pre-IPO investments in a portfolio: how to position them effectively

Investments in Pre-IPO companies can play a valuable role within a diversified portfolio, particularly for investors seeking exposure to innovation and long-term growth trends.

However, Pre-IPO companies should be positioned carefully. In most cases, such investments are best understood as:

• A complementary allocation to traditional investments such as listed equities or bonds
• A long-term investment with limited liquidity
• An opportunity-driven exposure where the expected risk and return is higher than in traditional investment products

Diversification across assets and a clear understanding of the individual target companies is essential.

New investment opportunities: access for retail investors

By offering investors access to invest in Pre-IPO companies, Invesdor gives retail investors access to a part of the market that has historically been available only to professional investors. This allows investors to participate in the potential return of some of the most innovative companies globally before they enter public markets and become available to the public.

At the same time, this access comes with increased complexity and risk. Understanding the structure, evaluating the underlying company, and taking a long-term view on the investment are all critical elements of a sound investment decision.

As with any investment, one principle remains unchanged:

Higher potential returns are always accompanied by higher risks, and building a diversified portfolio is key for sustainable success.

The post Pre-IPO Investing first appeared on Invesdor - Blog.

How do investments in healthcare help close gaps in care while also generating returns?  MedTech and healthcare investments are among the most stable and at the same time most innovative segments of the global healthcare market.   

MedTech and healthcare investments refer to capital allocated to companies that develop and commercialize medical technologies, digital health solutions, or healthcare infrastructure.

While many markets are subject to strong fluctuations, the demand for medical and healthcare services remains constant. It continues to grow with an aging population, increasing life expectancy  (according to the Deloitte Global Health Care Outlook 2025 the number of people over 65 in Europe will increase by around 30% by 2030) and the rising prevalence of chronic diseases such as diabetes and cardiovascular conditions.  

This demographic shift increases the pressure on healthcare systems and raises demand for efficient, technology-driven solutions.  

At the same time, healthcare systems are reaching their limits: hospitals are struggling with overload, waiting times are increasing, and modern diagnostics are not available to everyone. This is where new business models and medical technologies come into play. They create access where gaps previously existed and improve processes that have so far been inefficient.

For investors, this creates unique opportunities: MedTech and healthcare investments at Invesdor combine social impact with attractive return potential. Investors support concrete solutions with measurable impact.

Through Invesdor, investors gain access to MedTech and healthcare companies that have already overcome key hurdles and are preparing for the next stage of scaling. These projects combine societal impact with financial prospects. They are also aligned with the United Nations Sustainable Development Goals (SDGs).

MedTech & Healthcare Investments at a Glance  

MedTech and healthcare investments involve companies that improve medical care while building on robust business models.

In Europe, more than 90% of the MedTech sector consists of small and medium-sized enterprises (SMEs). This structure opens attractive opportunities for investors to enter early. At the same time, it requires a solid understanding of development stages, as smaller providers are more dependent on regulatory processes and scaling dynamics.

Germany, Switzerland, and the Netherlands are among the world’s most innovative locations.
Many companies here have overcome significant challenges: they are CE-certified, have completed clinical trials, or have generated their first revenue.  

Challenges and opportunities for Europe’s MedTech market   

According to the industry report   MedTech Europe Facts & Figures and MedTech Europe Facts & Figures 2024 the European medical technology market has been growing steadily at around 5% per year for several years.
 
Unlike traditional early-stage startups, many companies in this sector have already overcome key challenges: they are CE-certified, have completed clinical trials, or have generated initial revenues.  

For investors, this means they typically enter after this phase while still benefiting from significant scaling potential.

Typical segments include:  

• MedTech: devices, implants, and digital tools for diagnostics and therapy  
• Healthcare infrastructure: for example modern diagnostic systems and equipment fleets that hospitals can use and finance flexibly
• Digital Health:  telemedicine, platforms, and wearables 
  
  

Good to know: MedTech

• There are around 38,000 MedTech companies in Europe, about 90% of which are small and medium-sized enterprises (SMEs).
  
• The MedTech sector is one of the most innovative industrial sectors,  accounting for 
  about 8% of all industrial patent applications in Europe. 
  
• MedTech contributes significantly to the economy in terms of employment, exports, and innovation. The European MedTech industry directly employs more than 930,000 people. 
  
• The European MedTech market is estimated at around €170 billion for 2024, representing 
  about 26.4% of the global market. 

(Sources: MedTech Europe Employment & Companies , MedTech Europa Market , MedTech Europe Facts & Figures)  )

Health, innovation, and sustainability: Why Invesdor focuses on MedTech and Healthcare Investments 

According to an analysis by Deloitte („Europe’s MedTech Attractiveness“, 2025, Europe’s MedTech Report 2024) Europe is one of the most attractive regions for MedTech investments. In addition to a strong regulatory framework and excellent research, well-connected innovation clusters form the backbone of the European healthcare market.  

These innovation clusters include in particular the Nordic countries. Finland has developed into a leading location for MedTech start-ups. You can learn what enables this success in the article „8 Reasons for the Success of Finnish MedTech Companies“  

Health as a Growth Engine of the European Economy  

The EFPIA report “The Case for Investing in a Healthier Future for the European Union” also shows that every euro invested in the healthcare sector leads to higher quality of life, lower disease costs, and a more resilient economy in the long term. EFPIA concludes that health should be viewed not merely as a cost factor but as a driver of economic growth.

The European MedTech sector is strongly export-oriented. According to MedTech Europe 2024, around 60% of global medical technology exports originate from Europe. For investors, this means stable international demand, currency diversification, and growth beyond national markets.

Sustainability and Regulation Are Becoming More Important 

Invesdor views health as a central pillar of sustainable investments. Medical innovation directly improves the lives of millions of people while creating scalable business models. Every funding request is reviewed before being listed on our platform. The connection to the UN Sustainable Development Goals (SDGs) plays an important role. Depending on the project, the following goals are particularly relevant:

Good Health and Well-being (SDG 3)

MedTech and healthcare projects improve patient care. Modern diagnostics, digital systems, and new therapies enable earlier treatment and increase the chances of recovery. Every investment in this field directly contributes to improving health and quality of life.

Gender Equality (SDG 5)

Many MedTech and healthcare projects specifically address the needs of women in healthcare. From innovations in neonatology to technologies for female-specific diseases, solutions are emerging in areas that have long been neglected. Investments in such projects strengthen gender equality in healthcare and improve care for female patients.

Affordable and Clean Energy (SDG 7)

Energy efficiency also plays a role in healthcare. Modern devices and digital systems are increasingly designed to consume less electricity and to function reliably even in regions with unstable energy supply. For investors, this means supporting companies that use sustainable technologies while reducing costs for hospitals and patients.

Industry, Innovation and Infrastructure (SDG 9)

Healthcare investments promote modern technologies and the expansion of medical infrastructure. This includes robotic support systems, digital platforms, and flexible diagnostic solutions. Investors support companies that transform research innovations into market-ready products.

Reduced Inequalities (SDG 10)

Many healthcare projects make high-quality care accessible to more people. Pay-per-use models or mobile devices help hospitals in regions with weaker infrastructure. Investments therefore contribute to greater equality in healthcare systems.

Responsible Consumption and Production (SDG 12)

More and more companies are developing MedTech solutions that are resource-efficient and durable. They rely on reusable components and efficient production processes. Investors thus promote both medical impact and responsible resource management.

Partnerships for the Goals (SDG 17)

Progress in healthcare emerges through collaboration. Start-ups, hospitals, universities, and investors work together to bring innovations to market faster. Every investment strengthens this network and amplifies the impact of medical advancements.

We select projects that meet SDG standards. This ensures that investors support robust business models while contributing to solutions that promote ecological, social, and economic sustainability in healthcare. 

Challenges and Opportunities for Sustainable Investments in MedTech and Healthcare 

The healthcare and MedTech sector is considered one of the most exciting areas for investors—stable, innovative, and with clear societal relevance. At the same time, it is complex: regulations, clinical trials, and technological developments determine the pace and involve elevated risks. Investors should understand these mechanisms and be prepared for longer timelines. With foresight, real and sustainable value can emerge.

From Research to Practice: Examples of Successful MedTech Investments

The following examples illustrate different areas of modern MedTech investments. They range from highly specialized diagnostics to digital platform solutions and practical medical aids for everyday life. Each project addresses a clear clinical need, relies on scalable technology, and combines measurable healthcare impact with a sustainable business model. This highlights what matters to investors: evidence-based solutions, transparent milestones, and a clear path to scaling.

Megin: precise brain diagnostics with MEG technology, used worldwide

Megin is a Finnish MedTech company specializing in magnetoencephalography (MEG). This technology measures the magnetic fields generated by electrical signals in the brain, enabling physicians to analyze brain activity in real time.

This is particularly helpful for complex neurological conditions such as epilepsy or brain tumors. More precise diagnostics simplify the planning of surgeries and therapies.

Megin was founded in 1989 and is headquartered in Helsinki. The company is one of the global leaders in MEG technology. More than 120 systems are already installed in hospitals and research institutions. According to the company, it holds over 80% market share in new MEG system installations.

Clinical need and solution: precise mapping of brain function

Neurological diseases often present medicine with a precision challenge. For many procedures, it is crucial to accurately locate specific brain regions. 

Megin’s TRIUX Neo system measures the weak magnetic fields produced by neuronal activity. This allows functional brain areas to be visualized with extremely high temporal and spatial resolution. The method is non-invasive and does not involve radiation exposure. 

This information helps physicians plan procedures more precisely and reduce risks. 

Technology and status: established solution in a specialized market

Megin is considered an established provider in a technically demanding segment of medical technology. Its systems are used worldwide in hospitals and research institutions. Patents, specialized technical expertise, and regulatory requirements create barriers to entry for new competitors. At the same time, demand for precise brain diagnostics is increasing as neurological diseases rise globally.

Impact: better diagnostics and more targeted treatments

When physicians can localize brain functions more precisely, surgeries and therapies can be planned more effectively. This helps reduce risks and improve treatment outcomes. This aligns with the sustainability goal SDG 3 “Good Health and Well-being.” Advances in neurological diagnostics contribute to improving patient care in the long term.

Investor benefit: fixed-interest bond with clear terms

The company was financed through a bond. The terms are clearly structured:  

The financing round reached more than €3.5 million and was supported by more than 1,200 investors.

Megin generates revenue through the sale of MEG systems and service contracts for maintenance and operation. These service contracts provide recurring revenue.

Risks and management: investment cycles and regulatory requirements

The market for highly specialized medical technology is characterized by investment cycles. Hospitals often make large equipment decisions on a long-term and project-based basis. In addition, the installation of an MEG system requires specialized infrastructure such as magnetically shielded rooms. Regulatory requirements and production processes also shape the industry. Megin addresses these challenges through decades of industry experience, an installed system base, and international customer relationships.

Megin illustrates how specialized medical technology can combine investment opportunities with medical progress. Hospitals gain access to precise brain diagnostics while investors participate through a structured bond in the further development of this technology.

Pirche: AI-powered platform making organ transplantation more predictable

Pirche develops a digital diagnostics platform for transplant centers and clinical laboratories. After an organ transplant, immunological compatibility often determines how long a transplanted organ remains functional. Pirche focuses precisely on this point. The platform combines genetic typing with AI-driven modeling and supports physicians in identifying risks earlier and managing therapies more precisely.  

The need is significant. Many transplanted organs lose function within five to ten years. For patients, this means additional procedures, intensive treatments, and increased health burdens. Any improvement in donor organ matching and post-transplant care can therefore make a meaningful difference.

Clinical need and solution: better matching and more targeted follow-up care 

In transplant medicine, laboratories and medical teams already compare key parameters such as blood type and HLA markers. However, this information is not always sufficient to reliably estimate long-term risks. Pirche expands this analysis with additional immunological models.

The platform creates individualized immune risk profiles and supports clinical decision-making with advanced analyses. It uses data that is already available in many clinical laboratories, allowing the technology to integrate into existing workflows without requiring additional data collection.

Technology and status: patent-protected, scientifically documented, integrated into hospital IT

Pirche combines genetic typing with AI-based analysis to visualize complex interactions between donor and recipient. The underlying algorithms are protected by patents and have been examined in numerous scientific publications.

The platform has already been used in a large number of patient cases and further developed in collaboration with international hospitals and research institutions. Partnerships with laboratory providers such as Thermo Fisher Scientific and Werfen-Immucor facilitate integration into existing hospital IT systems.  

Impact: better treatment outcomes and more efficient resource use

When risks are identified earlier, follow-up care and immunosuppression can be adjusted more precisely. This can help reduce complications and extend the functional lifespan of transplanted organs. Such progress contributes to SDG 3 “Good Health and Well-being.”

Responsible use of medical resources also plays a role. Donor organs are extremely scarce. More precise matching can help extend their usability and avoid repeated procedures.

In addition, the analysis considers specific risk groups in transplant medicine, such as highly sensitized patients. This can help reduce inequalities in healthcare access.

Investor benefit: participation in a scalable B2B SaaS platform

The financing took place through an equity investment (security). The price per share was €15.85, with a minimum investment of 20 shares. Between 1.07% and 5.15% equity was offered at a pre-money valuation of approximately €36.86 million. In total, 578 investors participated.

The business model is based on software-as-a-service contracts with transplant centers and clinical laboratories. Hospitals access the platform through subscriptions, while partnerships with laboratory service providers enable further integration opportunities. Such models can generate recurring revenue when software becomes permanently integrated into clinical workflows.

The investor base includes experienced entrepreneurs and investors from the healthcare industry, including individuals with backgrounds in biotechnology. These investors contribute not only capital but also industry expertise and networks.

Risks and management: clinical adoption, regulation, and market dynamics

Digital diagnostics in clinical practice requires trust, strong evidence, and seamless integration. Pirche addresses these requirements through scientific documentation, a large number of evaluated cases, and IT partnerships. Nevertheless, the speed at which hospitals adopt new decision-support software into processes and budgets remains a key factor.

Regulatory requirements for healthcare software, particularly AI-based systems, also shape development. Pirche focuses strongly on the US transplant market, which offers opportunities but also introduces certain dependencies.

Pirche demonstrates how digital diagnostics can create value in a highly critical medical field. Hospitals gain a platform for improved risk management, patients may benefit from more stable outcomes, and investors participate in a patent-protected B2B SaaS model with documented usage and a clear commercialization strategy.

STIL: Steady Hands for an Independent Life

STIL  develops an orthosis that stabilizes the hands. A cup of coffee remains steady. A pen produces a readable signature again. A shirt button can be fastened without help. This is exactly where the STIL orthosis helps. It sits lightly on the forearm, specifically dampens tremors, and works immediately. Clinical data shows tremor reduction of more than 80 percent. Users regain control, can perform everyday tasks independently, and feel more confident.

Since 2023, STIL has been in use—first in the Netherlands and now also in Germany, Belgium, and Italy. Medical supply stores and orthopedic partners fit the orthosis and support users, bringing the solution directly into daily life.

Clinical need and solution: effective, practical, immediately available

Tremors significantly limit everyday life. Eating, writing, or dressing becomes difficult. Shame often leads to social withdrawal.

The STIL orthosis mechanically stabilizes the arm. It dampens uncontrolled movements without restricting natural motion. The effect is immediate. No electricity is required. The orthosis is easy to put on and adjust, even at older ages. Medical supply providers and orthopedic specialists support patients locally.

Technology and status: certification and clinical data

The STIL orthosis is CE-certified and FDA-registered. STIL operates under ISO 13485. A clinical study demonstrates its effectiveness for essential tremor, while additional studies are expanding its application to Parkinson’s disease and other movement disorders. The modular design adapts to different sizes and needs. Distribution partners in the Netherlands, Germany, Belgium, and Italy expand market reach. A new AI-based app supports screening and simplifies initial assessments for patients and distributors.

Impact: more independence, lower costs, stronger participation

Reduced tremors allow people to eat, write, and work independently again. This strengthens dignity and participation. Hospitals and insurers benefit from a non-invasive alternative to surgery or long-term medication. The orthosis helps reduce follow-up costs and relieve healthcare systems. It contributes to SDG 3 and, through durable and repairable product design, also supports SDG 9 (Industry, Innovation and Infrastructure), SDG 10 (Reduced Inequalities), and SDG 12 (Responsible Consumption and Production).

Investor benefit: validated technology, rapid distribution, large market

STIL combines medical benefit with a clear go-to-market strategy. Distribution runs through an established network of medical supply stores and orthopedic partners, including Ottobock (Italy), STOLLE (Germany), and VIGO (Belgium). The addressable market in the EU and the US is worth billions. Renowned investors such as Health Innovations, Rabobank, the EIC Accelerator, and the Brain Foundation Netherlands support growth. The latest valuation was €10 million pre-money. The round offered strengthened shareholder rights for new investors and followed a clear exit logic.

Risks and management: reimbursement, adoption, scaling, regulation

Reimbursement pathways vary by market. STIL works with pilot centers, key opinion leaders, and partners to secure coverage. Adoption in daily practice is supported by training, simple fitting processes, and distributor support. Scaling and supply chains are planned step by step with clear quality processes. CE certification, FDA registration, and ongoing studies reduce regulatory uncertainty. The AI screening app improves matching and increases success rates in patient care.

STIL brings a clinically validated, non-invasive solution into standard care. Patients gain independence in daily life. Healthcare providers operate more efficiently. Investors gain access to a scalable MedTech company with a clear distribution strategy, growing partnerships, and strong validation.

Healthcare investments: benefits for people and investors

Investments in MedTech and healthcare combine economic stability with social impact. They allow investors to actively contribute to improving medical care while achieving attractive long-term returns.

MedTech and healthcare projects are a valuable addition to a diversified portfolio. They respond to global megatrends such as demographic change, technological innovation, and the growing demand for efficient healthcare.

For Invesdor, it makes sense to focus on companies that:

develop new medical technologies that improve diagnostics, therapy, or care,
optimize existing systems by digitizing processes or making devices more sustainable, 
expand medical infrastructure, for example through pay-per-use models or mobile solutions,  
scale internationally to bring innovations to new markets more quickly.  

Such projects meet clear sustainability and quality standards and offer strong value creation potential.

The healthcare sector is considered particularly resilient: people require medical services regardless of economic cycles. Healthcare investments therefore offer long-term stability. Companies with CE certifications and validated clinical data increasingly meet strict regulatory requirements, which further strengthens their market position.

MedTech and healthcare offer growth potential through scaling, market expansion into new regions, and possible exits to larger corporations. Investors benefit from the combination of measurable impact, innovation dynamics, and predictable return models—whether through bonds with fixed interest or equity investments with upside potential.

As with any asset class, risks exist. In the MedTech sector, these include potential delays in studies, regulatory changes, or longer approval processes. Liquidity challenges or dilution in follow-up financing rounds can also influence return profiles. Equity investments also carry the risk of partial or total loss.

A structured due diligence process such as the one applied by Invesdor helps reduce these risks.

Projects are evaluated based on financial metrics, clinical evidence, ESG criteria, and sustainability standards. This provides investors with access to vetted, viable, and impact-oriented companies.

An investment in the healthcare sector allows investors to influence the future of medical care. Those who invest in MedTech and healthcare contribute to accelerating innovation, improving patient access to treatment, and strengthening healthcare systems worldwide—while combining this social contribution with a clear economic perspective.

God to know:  How Invesdor selects Healthcare and MedTech projects 

Invesdor reviews every project through multiple stages to ensure quality, transparency, and sustainability:

Only about 5% of submitted projects make it onto the Invesdor platform. Further details about the evaluation process for investment opportunities can be found here: Investment Evaluation Process.

Invest in health now: your chance to actively shape the future! 

Healthcare and MedTech investments combine financial stability with social impact. Investors support innovations that improve lives—from advanced diagnostics and digital health solutions to new medical technologies. At the same time, they benefit from a growth market that is largely independent of economic cycles.

Those who invest in this sector promote progress, improve access to better care, and actively shape the future of medicine.

Discover current investment opportunities on Invesdor:
projects that combine medical progress with economic potential.

Start today and invest in a healthier future! 

The post MedTech and Healthcare Investments: Opportunities, Risks, and Examples first appeared on Invesdor - Blog.

Think about the last time you threw out an overripe banana, a handful of wilting greens, or the pulp left over after pressing juice. Now multiply that by every farm, food factory, and supermarket across Europe.

The number is hard to sit with. According to Eurostat, the EU wastes over 59 million tonnes of food every year, worth an estimated 132 billion euros. And that does not even count what disappears at the farm gate before it reaches anyone.

The default response for most of this waste has been the same for decades: burn it, compost it, or run it through a biogas plant. These are not bad options. But in a world where animal protein demand is set to climb 52% by 2050 and Europe imports nearly 89% of its phosphate fertilizers from politically unstable regions, they start to feel like we are leaving a lot on the table.

What is the circular economy? The circular economy is an economic model that eliminates waste by keeping resources in use for as long as possible – extracting maximum value from them, then recovering and regenerating products and materials at the end of their service life. Applied to food, it means treating organic residues not as waste to dispose of, but as inputs for new production cycles.

What if this waste was never really waste at all?

Where does Europe’s food waste actually come from?

Most people picture overflowing kitchen bins when they hear “food waste.” The reality is messier than that. The EU’s waste problem is spread across the entire food supply chain, from field to factory to fork.

Here is the breakdown, according to the European Environment Agency:

• Households are the biggest culprit, responsible for around 55% of total food waste
• Food processing and manufacturing adds roughly 24 kg per person every year
• Farms themselves contribute about 10 kg per person per year before food even leaves the field

But the less-talked-about side of the story is agricultural side streams. The stuff that does not make headlines: the peelings and pomace from fruit and vegetable processing, the manure and slurry from livestock farms, the whey left over from making cheese, the husks and bran from grain milling. Tonne after tonne, day after day, at every farm and food facility across the continent.

Zoom out to the global picture and it gets even harder to ignore. The UN Environment Programme’s Food Waste Index 2024 puts global food waste at approximately 1.05 billion tonnes in 2022 alone. That is around 19% of all food produced for human consumption. Put it another way: if food waste were its own country, it would be the third largest emitter of greenhouse gases on the planet, behind only the USA and China.

Why burning food waste is not a Circular Economy solution

Incineration turns a resource problem into a loss problem. You get energy once, and then everything else is gone forever.

For decades, sending organic waste to incineration or biogas plants has felt like a reasonable solution. You get energy out of it. That counts for something. But what gets quietly ignored is everything that goes in and never comes back out.

Take phosphorus. It is a finite, non-renewable mineral with no synthetic substitute, and it is essential for growing food. Europe imports nearly all of it, much of it from geopolitically fragile regions. When phosphorus-rich organic waste goes into an incinerator, it is not recycled. It is destroyed permanently. There is no getting it back.

The same is true for the proteins, fats, and micronutrients locked inside food side streams. We spent land, water, and energy producing them. Then we burn them and call it waste management.

The circular economy framework asks a different question entirely. Not: how do we get rid of this as cheaply as possible? But: how do we get the most value back out of it? That one shift in thinking changes everything that follows.

What is insect bioconversion, and how does it work?

It sounds niche. The science behind it is anything but.

One of the most compelling developments in circular economy research over the past five years is surprisingly low-tech: insects. Specifically the black soldier fly, a species that turns out to be extraordinarily efficient at converting organic waste into three useful things at once.

Feed it your food residues and you get back:

• High-quality protein, suitable for animal feed, aquaculture, and pet food
• Insect fat, which can replace conventional oils in industrial and feed applications
• Frass, an exceptionally nutrient-rich organic fertilizer that puts phosphorus straight back into the soil where it belongs

The climate comparison is striking. Life-cycle assessments put black soldier fly larvae at roughly 1.5 kg of CO2-equivalent per kilogram of protein produced. Beef sits at around 10 kg for the same amount. Research published in Frontiers in Sustainability found that using larvae to process food and agricultural residues can cut methane emissions by up to 80% compared to standard waste disposal.

What makes this practical rather than theoretical is the flexibility. The larvae are genuinely not picky. Fruit peelings, grain residues, wine pomace, dairy surpluses, poultry litter: it all works as feedstock. If one source dips seasonally, another fills the gap.

And the results hold up at scale. A Dutch study documented around 20,000 tonnes of insect protein produced annually from food waste in the Netherlands alone. A case study in Uganda found that applying BSF frass as fertilizer increased maize yields by 30%. These are not projections. They are documented outcomes.

Is insect protein legal in the EU? What the regulations say

For a long time, regulation was the biggest bottleneck. Insect-derived proteins existed. The market for them existed. But the legal framework to actually use them in mainstream feed was not there.

That started to change in 2017, when the EU authorized insect proteins in aquaculture feed. Then in 2021, the authorization extended to poultry and pig feeds. That second step in particular unlocked a much larger market almost overnight.

On top of that, the EU has now introduced binding food waste reduction targets, requiring member states to cut food processing waste by 10% and retail and household waste by 30%, both by 2030. For food producers and processors, that means rising pressure to find better uses for their organic residues, and rising costs if they do not.

The market is moving accordingly. IPIFF estimates that EU production capacity could reach up to 1 million tonnes of insect meal annually by 2030. The global insect feed market is projected to grow at around 22% per year, reaching 3.6 billion dollars by 2031. The regulatory window is open. The commercial window is opening with it.

Austria’s food waste problem – and its Circular Economy opportunity

Austria is one of the most organically farmed countries in the world. It is also sitting on some of the largest untapped organic waste streams in Europe.

Austria leads the EU in organic farmland. As of 2023, nearly 27.4% of all agricultural land is organically managed, already surpassing the EU’s own 25% target for 2030. That is something to be genuinely proud of. But it also means Austria generates enormous volumes of agricultural side streams, from the valleys to the Alps, every single day.

Here is where it gets interesting. The industries generating the most organic waste in Austria are not factories in the distance. They are the backbone of the country’s rural economy:

• Dairy farming – around 22,700 Austrian dairy farmers produce 3.6 million tonnes of raw milk annually. Cheese production, Austria’s largest dairy export, leaves behind significant volumes of whey surplus, a protein-rich stream that is costly to dispose of and ideal as circular feedstock.
• Cattle farming – Austria has approximately 1.835 million cattle, most on small family farms across mountainous regions. Each animal produces manure daily, and with over 75,500 livestock farms in the country, that adds up to an enormous continuous residue stream.
• Fruit and vegetable processing – Austria is an agricultural country with strong regional fruit and wine production. Apple pomace alone accounts for 25% of fruit weight after pressing, and grape marc from wine regions like Burgenland and Styria adds millions more tonnes per harvest.
• Food industry and catering – Austria generates approximately 1 billion euros worth of avoidable food waste every year, with agriculture contributing around 30% of the total. That is not just an environmental issue. It is a cost that farms and processors are actively looking to reduce.

What makes Austria particularly well-suited for circular systems is exactly what defines its agriculture: small-scale, family-run, geographically spread across regions. A modular approach that processes residues on-site, at the farm or facility where they are generated, fits this landscape far better than centralised industrial solutions ever could. It does not need to ship waste across the country. It closes the loop right where it starts.

Why Circular Economy startups are attracting impact investors

Here is what makes this space genuinely compelling from an investment perspective, beyond the environmental story.

Companies building circular systems around organic waste are not selling a product into an existing market. They are solving two problems at the same time:

• They give agricultural and food industry clients a cheaper, better alternative to waste disposal
• They produce high-value outputs, protein, fat, fertilizer, that replace expensive imported materials

That dual model is hard to replicate and creates a natural defensibility. It also means the business case does not depend on a single price signal. When disposal costs rise, the value proposition strengthens. When feed prices rise, so does the value of the output.

At Invesdor, we look for companies where the impact case and the financial case are telling the same story. The circular economy space around organic waste is one of the clearest examples of that overlap we see right now. The science is solid. The regulation is moving in the right direction. And the market need is not going anywhere.

The bottom line

A banana peel is not waste. Fruit pomace is not waste. Poultry litter is not waste. They are packages of protein, fat, and minerals that took land, water, energy, and time to produce.

Sending them to an incinerator destroys all of that embedded value in one go. The circular economy is not asking us to be less efficient. It is asking us to finally be honest about what efficiency actually means.

In a world where protein demand is climbing, fertilizer imports are a geopolitical risk, and food waste is costing Europe over 132 billion euros a year, the most efficient thing we can do is stop treating our most valuable residues like garbage.

The technology is here. The regulation is catching up. The only question left is whether the capital will follow.

Frequently Asked Questions

What is insect bioconversion?

Insect bioconversion is the process of using insect larvae – most commonly the black soldier fly (Hermetia illucens) – to convert organic waste into high-value outputs including protein meal, fat, and frass fertilizer. The larvae consume food residues and agricultural side streams, and are then harvested to produce feed ingredients that replace conventionally produced alternatives.

Is insect protein approved for use in animal feed in the EU?

Yes. The EU authorised insect-derived proteins in aquaculture feed in 2017 (Regulation EU 2017/893) and extended this to poultry and pig feeds in 2021 (Regulation EU 2021/1372). Insect protein is not currently approved for use in ruminant feed within the EU.

How much CO₂ does insect protein produce compared to beef?

Life-cycle assessments put black soldier fly larvae at approximately 1.5 kg of CO₂-equivalent per kilogram of protein produced. Beef sits at around 10 kg for the same amount – making insect protein roughly 6 to 7 times less carbon-intensive.

How much food waste does Austria produce each year?

Austria generates approximately 1 million tonnes of food waste per year, equivalent to around 134 kg per person. Roughly 58% of this comes from private households. Agriculture contributes around 30% of avoidable food waste, estimated at close to €1 billion in value annually. Austria’s circular material use rate currently stands at 14.3%, against an EU target of 18% by 2030.

What is frass and why does it matter?

Frass is the organic byproduct of insect rearing – a mixture of insect excrement, shed exoskeletons, and residual feed material. It is exceptionally nutrient-rich and acts as an organic fertilizer, returning phosphorus and nitrogen to the soil. Field trials have shown BSF frass can increase crop yields by up to 30% compared to conventional fertilization, making it a key output of circular insect farming systems.

The post Circular Economy: How food waste is becoming protein first appeared on Invesdor - Blog.

Does it quietly sit on a balance sheet or does it build solar sites, accelerate medical innovation and create measurable change?

That is the core question behind impact investing.

At Invesdor, we see every day how intentionally deployed capital contributes to real-world progress. When investors choose where their money goes, they enable financially viable companies to scale solutions that address concrete social and environmental challenges.

Impact and financial returns are not opposites. When done right, they reinforce each other.

Impact investing in practice   

Impact investing focuses on directing capital towards companies that generate positive social or environmental outcomes alongside financial returns. Rather than treating impact as a secondary effect, impact investing integrates measurable impact directly into business strategy and growth.

Across Europe and beyond, more investors are actively seeking opportunities to align their capital with long term sustainability and real world outcomes.

Impact starts with where your capital goes

Impact does not happen automatically. In impact investing, it is the result of deliberate investment decisions. Investors allocate capital to businesses that address real world challenges and are designed to scale, often at stages where traditional bank financing is limited.

Across sectors such as energy, healthcare and consumer goods, impact investing supports companies at different stages of growth and market expansion.

Examples illustrate what this looks like in practice.

Clean energy that strengthens local economies 

In Uganda and Rwanda, power outages are part of everyday life for many small businesses. An interrupted cold chain can spoil an entire delivery. An hour of downtime means lost revenue. 

Sawa Energy faced the challenge of expanding renewable energy where it is urgently needed. Between 2022 and 2023, Sawa Energy raised €1,399,734 via Invesdor. This funding played a catalytic role by unlocking additional financing and accelerating the rollout of renewable energy infrastructure in Uganda and Rwanda.

The funding enabled:

• the commissioning of 54 solar sites 
• 3.6 MWp of installed solar capacity 
• 1 MWh of battery storage 
• an estimated CO₂ reduction of around 2,400 tons 

For small and medium sized businesses, this translates into fewer power outages, lower energy costs and greater operational reliability. In regions where grid instability is common, reliable electricity is not a luxury but a foundation for economic growth. 

Beyond infrastructure deployment, Sawa Energy expanded its operations and grew its core team from 3 to 17 permanent employees. This strengthened local expertise and created a solid foundation for long term impact and further scale. 

This is investor capital turning into climate action and economic resilience on the ground. 

Medical innovation that changes everyday life 

In the Netherlands, patients are now testing a wearable artificial kidney at home for the first time. The NeoKidney is developed by Nextkidney, in collaboration with UMC Utrecht and the Nierstichting.

For people with kidney failure, dialysis often means long hospital sessions several times per week, placing a heavy burden on daily life. The NeoKidney aims to make dialysis portable, allowing treatment at home or while travelling.

The ongoing clinical study focuses on safety, effectiveness, ease of use and the impact on daily routines and quality of life. As lead researcher Karin Gerritsen explains, dialysis is life saving but also demanding. A wearable artificial kidney can give patients more freedom and autonomy.

This kind of progress is only possible when innovation receives the funding it needs to move from concept to real world testing. In 2023 alone, more than 1.200 investors contributed over €4 million via Invesdor, supporting impact driven healthcare solutions like this one.

Here, impact is felt directly by people in their everyday lives.

Nordic health technology gaining international attention

Koite Healthcare was also facing a decisive step. With Lumoral, the company developed a technology that treats gum inflammation at home. It specifically targets bacterial biofilm, does not use chemicals, and protects the natural oral microbiome. 

A medical device developed by Koite Healthcare was recently featured on German national television on ARD’s Morgenmagazin on 27 January 2026, reaching millions of viewers. During a segment on oral health, Professor Werner Birglechner, one of Germany’s leading dental educators, highlighted Lumoral as a breakthrough in at home gingivitis care.

The technology addresses the root cause of inflammation by disrupting bacterial biofilm and significantly reducing harmful bacteria, without chemicals and without damaging the beneficial oral microbiome.

Expert validation of this kind on national television is rare. It underscores strong clinical credibility and highlights growing international momentum in Europe’s largest healthcare market.

What these impact investing examples show 

While operating in different sectors and regions, these examples illustrate how impact investing works in practice. They address clearly defined challenges, focus on scalability and make their social and environmental impact measurable.

From renewable energy projects in East Africa to medical innovation across Europe, impact investing channels capital to solutions that might otherwise struggle to secure growth financing, particularly in critical development stages.

Impact does not happen by accident. It is the result of deliberate allocation decisions, transparency and engaged investors.

So do you really make a difference as an investor?

Yes, when you invest intentionally through impact investing.

The stories of Sawa Energy, Nextkidney and Koite Healthcare demonstrate how investments via Invesdor enable tangible projects and innovations, create measurable social and environmental impact and support mission driven companies in scaling sustainably.

Impact is not a side effect. It is the result of conscious choices, transparency and engaged investors.

Investing with purpose

As an investor, you are not just providing capital. You are enabling solutions.

Whether it is clean energy for businesses in East Africa or greater freedom for dialysis patients in Europe, your investment can bridge the gap between promising ideas and real world change.

For investors interested in European impact investing opportunities with measurable outcomes, Invesdor provides transparent access to curated projects across multiple sectors and regions.

That is what making a difference truly looks like.

Discover new impact investment opportunities
Subscribe to receive curated updates on impact investing, selected projects, and developments across energy, healthcare, and sustainable consumer goods.

The post Impact Investing: Do I really make a difference as an Investor? first appeared on Invesdor - Blog.

When energy supply suddenly becomes fragile

And suddenly the power is out. Countless households must be evacuated. People spend the night in poorly heated gyms—including those who require special care. This happened in January 2026 in Germany’s capital, Berlin. 

For a long time, energy in Europe was considered a given. But events of recent years—from geopolitical tensions and extreme weather to local blackouts like in Berlin—have shown how vulnerable even highly developed energy systems can be. 

These experiences make one thing clear: energy security is not just a national issue. It is a European task—technically, economically, and politically. And there are solutions if we think beyond borders. 

Europe’s energy transition: from a technology issue to an infrastructure challenge  

Europe is pursuing ambitious goals in the expansion of renewable energy. Solar and wind power are being massively scaled up in nearly all member states. Solar energy has become a central pillar of electricity generation in many European countries. From Southern Europe to Scandinavia, installed capacity is growing—on residential rooftops, in industrial facilities, and in large-scale solar parks. Wind power complements this generation, especially in coastal areas and offshore. (Quelle: Solarpower ) 
 

Solar and wind energy are becoming more important 

• Solar will cover around 13.4% of EU 
  electricity demand in 2025 (2023: 9.7%). 

• In June 2025, solar became the EU’s largest 
  electricity source for the first time.  

• Wind and solar together now supply over 
  30% of electricity, increasingly displacing 
  fossil fuels.  
  
  (Sources: Solarpowereurope, Wikipedia )  

For Europa this means: 

• high scalability 
• regional value creation 
• reduced dependency on energy imports 

Manufacturers of solar panels and wind components are an essential part of the system. They drive technological innovation, expand production capacity, and ensure stable supply chains—all prerequisites for the continued expansion of renewables in Europe. 

But with this growth, the energy system itself is changing. Traditional power plants delivered electricity on demand; renewables are weather-dependent. Consumption follows different patterns: industry, households, mobility and digitalization create demand peaks at specific times of day. 

This leads to imbalances. And this is where it becomes clear that the energy transition is not just about technology—it’s about infrastructure. It’s about the interaction between generation, storage, grids and intelligent control—real, investable structures. 

Energy generation in Europe: solar and wind as the foundation

Solar and wind power form the foundation of renewable energy generation in Europe. Both technologies are mature, scalable and competitive in the long term. At the same time, Europe is developing new production capacities for solar panels, inverters and wind components to stabilize supply chains and reduce dependencies. 

For investors, projects in this area are attractive when they are well integrated into regional energy structures. Key factors include site quality, grid connection, operational concepts and long-term marketing models. Pure generation without storage or flexible marketing is increasingly hitting economic limits. 
 

Case study: scalable solar energy (financed via Invesdor)

A good example of system-oriented solar energy is  Der Solarteur. The company plans and installs photovoltaic systems, as well as heating and battery systems, for the housing sector and for commercial and industrial customers. 

Since its founding in 2021, Der Solateur has completed over 2,800 installations. It addresses a key bottleneck of the energy transition: the need for scalable, qualityassured solutions to quickly decarbonize existing buildings, especially for large housing providers. 

Digitalized processes, reliable supply chains and experienced installation teams allow the execution of large-scale projects—a clear advantage in a fragmented market. A framework agreement with one of Europe’s largest housing companies highlights the company’s strategic positioning. 

Remarkable:
The project sparked strong interest among investors: €1.1 million was funded in less than 48 hours.

The market shows: generation remains the foundation—but it’s only the first step.   

This is where sustainable investment projects come in, financing the construction and operation of such storage facilities. 
 

Battery storage: the key to Europe’s energy security

Renewable energy is generated when the sun shines, the wind blows, or water flows. It depends on the weather and, unlike fossil fuels, cannot be easily controlled by humans. So how can we still use these forms of energy reliably and make them predictable? Battery storage fills a crucial gap in Europe’s energy system. It absorbs electricity when supply is abundant and releases it when demand and prices rise. This makes renewables more predictable and economically viable. 

Technically, battery storage systems perform several tasks: 

• stabilizing power grids   
  
• balancing load peaks 
  
• reducing curtailment of generation plants .  

Europe’s battery storage market is growing rapidly. According to the European Market Outlook for Battery Storage 2025–2029 installed capacity is set to grow significantly in the coming years—driven by rising demand for flexibility.

Large-scale storage, neighborhood solutions, and hybrid solar-storage projects are developing into infrastructure investments. They help make national grids more resilient to unexpected events.

For households, businesses and entire neighborhoods, storage solutions can increase independence from central grids.

Case study: battery storage for system stabilization (financed via Invesdor) 

Two examples of grid-supporting Battery Energy Storage Systems (BESS) on Invesdor 
are  BESS Remscheid Luckhausen and BESS Wehr. Both use battery systems to store surplus  electricity from renewable sources and feed it back into the grid later. 

These systems balance load peaks, reduce curtailment of solar and wind power, and contribute to grid stability. They exemplify how battery storage becomes a core part of energy infrastructure—both technically and economically. Such projects also open up new revenue potential through flexible electricity trading and increase the predictability of renewable energy.  
 
For investors this means: storage is no longer a supplement—it’s a key value driver. 

Energy infrastructure: the often underestimated investment factor

Between generation and consumption lies infrastructure. Grids, substations, connections, installations and maintenance ensure that renewable electricity actually reaches where it’s needed.

This area is highly relevant for sustainable investment. Infrastructure projects stand out through long-term use, predictable income, and high system relevance. They form the backbone of the energy transition and are being promoted and expanded at the European level.

Infrastructure may be less visible than solar panels or wind turbines – but it’s often decisive for the system’s overall stability and profitability. 

Case study: wind power as integrated energy infrastructure (financed via Invesdor) 

Wind power creates the most value when it is operated continuously, at scale and integrated into the grid. Projects like Windpark Fryslân and Westermeerwind on Invesdor do just that. 

Both parks feed significant amounts of renewable electricity into the grid and contribute reliably to Europe’s energy supply. What matters is not only the generation capacity but the integration into existing grid infrastructure. As long-term infrastructure projects, these wind farms combine renewable electricity production with energy security and regional value creation.

Digital control: efficiency that drives returns 

As energy systems become more decentralized, digital control grows in importance. Smart grids and energy management systems coordinate generation, storage and consumption in real time. They determine when electricity is stored, used, or traded.

Digital solutions are a key factor in the profitability of modern energy projects. They increase income predictability, reduce losses, and allow flexible responses to market prices. Technology and software are closely tied to stable returns. 

Investing in renewable energy in Europe: projects with substance 

This systemic perspective opens up new opportunities for investors. Potential lies not just in individual technologies but throughout the entire value chain:

• Generation
• Storage
• Infrastructure
• control 

Europe is committed to long-term regulation, clear climate goals, and continuous energy infrastructure expansion. This creates planning security—a crucial factor for sustainable investment.

Renewables in Europe are no longer just a climate issue. They’re part of a structural transformation of the energy supply. Those who invest are not betting on isolated products but on a system built on collaboration, scalability and long-term stability. 

Renewable energy in Europe: sustainable investment with impact 

Transforming Europe’s energy system requires significant investment. Generation, storage, grids and digital control must grow in parallel to maintain system stability.  

“Renewable energy investments in Europe are no longer just about climate impact — they are about resilience, security and economic sovereignty. Solar, wind, storage and infrastructure only create real value when they are understood as one interconnected system. Investing in this system means strengthening Europe’s energy independence, stabilising supply in times of crisis, and building long-term, infrastructure-backed returns for investors. That combination of impact and resilience is what makes renewable energy such a compelling investment today.” (Christopher Grätz, CEO Invesdor Group)

Those who participate in these projects invest in infrastructure with societal relevance. This is not about short-term trends but about assets with long-term value and impact. 

Sustainable energy projects combine economic rationale with the creation of a future-proof energy system for Europe. 

Interested in learning more about investment opportunities in the European energy sector? Find in-depth information and current projects in the field of renewable energy here: 

The post Investing in renewable energy first appeared on Invesdor - Blog.

1. Keep a Cool Head 

In economically stormy weather, it’s tempting to react emotionally. However, such reactions are not always beneficial. Market downturns are unpleasant but part of the investing journey. Those who act out of fear often miss the recovery that follows shortly after. In times like these, calmness and patience are your greatest allies. 

2. Diversify – stay close to home

Diversification is essential in any market, but especially when volatility is high. By spreading your investments across different sectors, regions, and types of companies, you limit risk and increase your chance of stable returns. Don’t put all your eggs in one basket — build a well-balanced, resilient portfolio. But diversification doesn’t always mean going global. In fact, focusing on stable, locally rooted companies can be a smart move — especially now. 

That’s why Invesdor offers direct investments in Northern European companies — businesses that are not only based here but also generate most of their revenue within the region. These are companies you can understand, support, and grow with. Unlike many stock-listed multinationals with high exposure to global uncertainty, our companies are anchored in local economies and have a strong regional focus. 

What exactly does investment diversification mean?
The article “Investment Diversification Made Simple” explores key principles in more detail, provides concrete examples, and offers helpful context.

3. Look Beyond the Stock Market

One of the advantages of direct investing is the ability to invest in non-listed, local companies — businesses that are not subject to daily stock market fluctuations and short-term investor sentiment. These companies, often rooted in local European communities, tend to have a long-term focus and sustainable growth ambitions. By supporting them, you’re investing in the strength and resilience of the (Northern) European economy. 

4. Invest in Sustainable Companies

Sustainable businesses — those focused not just on profit but also on people and the planet — often prove more resilient in uncertain times. These companies build for the long term, maintain strong relationships with stakeholders, and take a future-focused approach. Especially now, it’s worthwhile to support businesses that aim to make the world a better place. 

In Conclusion: Think Long-Term 

Economic shocks are often temporary. A well-diversified portfolio, on the other hand, is built to last. Don’t get caught up in the noise of the moment. History shows that markets tend to recover after periods of turmoil. At Invesdor, we help you invest directly in companies that matter — close to home, with a long-term vision. Stay calm, stay close, and invest wisely. 

The post Direct investing in turbulent times: stay calm and diversify  first appeared on Invesdor - Blog.

Alternative funding solutions increasingly complement traditional funding provided by banks and public support institutions. Alternative funding solutions, such as crowdfinancing, fill the financing gap left by traditional financiers, which particularly benefits fast-growing SMEs and innovative scale-ups who face challenges in.  The Finnish market is small, which means companies have to go abroad at quite an early stage if they want to scale. But scaling internationally requires capital. At the same time, access to capital is limited.  Invesdor plays a key role here by serving an underserved market and giving Finnish companies access to funding alternatives that would otherwise be hard to reach. 

That is what impact means to me—bringing together capital, knowledge, and connections to support sustainable solutions and above all create jobs where people can earn a living. 
That is exactly what I want to build. 

At the same time, the country is considered one of the most digital economies within the EU, offering excellent infrastructure for research and development. With 5.6 million inhabitants, Finland is the least populated of the Nordic states, yet it impresses with high innovative capacity, a well-educated workforce, and an ongoing transformation toward sustainable industries and green energy. Advancing digitalization and the expansion of renewable energy also open up new opportunities for investors. 

Niklas Green has been following this market for many years and understands its particularities like few others. As newly appointed Commercial Director Finland at Invesdor, he now takes on the lead of Invesdor in Finland and plays a key role in developing the Finnish deal flow and expanding the investor base. In this interview, he shares his perspective on the current market situation, his strategic priorities, and the outlook for Finland in a broader European context. 

The Finnish market is undergoing change. How do you currently assess the Finnish market?  

Niklas Green: The Finnish economy has not been growing for 20-years. That’s a fact. But I don’t think the market will get better if we watch and wait. It’s time to take an active role in changing the course. While the economy as a whole has not been growing, we have a lot of companies with great potential. The problem is more often than not that due to a lack of funding, these companies either cannot scale or are sold at an early stage. 

The underserved Finnish capital market offers investors with a lot of opportunities for investment opportunities with an attractive risk-return relationship. We have a lot of small and medium-sized enterprises (SMEs) in Finland that are innovative and future-oriented with a desire to grow. However, the lack of viable financing opportunities means these companies cannot access the capital they need to invest in growth.  

The reason lies in the structure of the capital markets. Banks in Finland are few and the ones that are there emphasize historical indicators: solid balance sheets with tangible assets, long-standing profit records, and extensive collateral. But these are exactly the things many modern companies cannot provide, as they often have intangible assets, such as software, but limited tangible assets. What matters most is future potential and scalability. After all, returns are paid with future profits, not past profits. 

This creates a structural financing gap between ambitious companies and the conservative requirements of the banks. Closing this gap is not just a challenge—it’s also a great opportunity for everyone involved. 

When traditional bank financing is no longer sufficient, what are the biggest challenges for companies in Finland?  

Niklas Green: Many companies in Finland face a similar issue. As soon as they want to grow or plan larger investments, they encounter limitations in financing. Over the past few years, banks have changed significantly. Their main focus is on risk assessment and requiring collateral that many growth-oriented companies cannot provide. 

One common example is young companies with innovative business models. Since they lack a long track record, they are often unable to secure loans. Only those who can offer personal guarantees or other forms of security may gain access to capital. However, many entrepreneurs are reluctant to take the route of personal guarantees, especially due to past experiences during the banking crisis of the 1990s, when many entrepreneurs lost everything, they had and ended up in life-long indebtedness due to such guarantees. 

Another challenge is the lack of financing options in Finland when it comes to debt capital above a few hundred thousand euros. For amounts up to maybe 200,000 euros, there are multiple options for funding. Beyond that, the financing landscape becomes very limited. This gap affects many businesses and, at the same time, opens up opportunities for alternative solutions and investors who want to serve this need. 

What role do alternative financing models play in Finland, and how does crowdinvesting help close the gap? 

Niklas Green: When banks are cautious, companies need other ways to raise capital. Unfortunately, Finland lacks reliable structures in this area. Especially for debt amounts between 200,000 – 300,000 and 1,000,000 euros, there are very few viable options. As a result, many growing companies with a solid business cannot obtain financing. 

This is where alternative financing steps in as a relevant solution relevant. Through this financing companies gain access to capital when traditional routes, such as bank financing, are unavailable. Crowdfinancing enables a company to pool capital from many individual investors with the help of an intermediate, or financing platform. This creates an alternative form of financing that is appealing to both companies and investors. 

For companies, it unlocks access to capital when traditional funding is unavailable. For investors, it creates an opportunity to earn an attractive return on capital and support Finnish growth companies that often go unnoticed. In this segment, demand for capital is high, while supply is limited. That imbalance creates an attractive risk-return relationship. 

Where do you currently see the most promising investment opportunities in Finland? 

Niklas Green: The IT and tech sectors have always been strong in Finland. However, I find it particularly exciting to look at companies that frequently remain under the radar. These are solid businesses in traditional industries that may not seem flashy, but offer high stability and steady growth. Often referred to as hidden champions by my German colleagues, these companies form the backbone of the Finnish economy. If we could only ensure that these hidden champions would have accessed the working capital they need to grow, we could probably solve a major part of the no-growth puzzle. 

Are there other sectors that are changing or have already changed?  

Niklas Green: Artificial intelligence is a growing sector, closely linked to the rapidly expanding data center industry. Finland has clear advantages here, such as low energy prices and a stable climate. Waste heat from data centers can be reused efficiently, for example to heat buildings using renewable energy. These types of smart solutions highlight the innovation potential of the Finnish market.  

And the defense industry has evolved significantly. Finland shares more than 1,100 kilometers of border with Russia, making national security an important topic. For a long time, the defense sector was considered off-limits for investors. That perception virtually changed overnight, and many now see that defense capabilities can align with ESG criteria. Security is increasingly viewed as an essential part of sustainable development.  

What role does Europe play in financing Finnish companies? 

Niklas Green: Many Finnish companies are well-positioned, but struggle to access traditional financing within Finland. One of the reasons is the small number of banks in the country, most of which take a cautious approach to lending. In this context, access to European capital can make a significant difference. 

Our network allows us to connect Finnish companies with investors from across Europe. These investors bring not only capital, but also valuable experience, networks, and a desire for stable investment opportunities. Because capital availability is low in Finland, interest rates tend to be higher than in many other European markets. This creates attractive returns for investors while keeping risks manageable. 

Why is this particularly interesting for investors? 

Niklas Green: In today’s market environment, it is difficult to find investments that have an attractive return with manageable risk. The Finnish market offers exactly this combination. There is a constant need for financing, particularly among medium-sized businesses, and very little competition when it comes to providing capital. Investors who enter the market early have the opportunity to actively shape Finland’s economic development and secure a strong position in the market. 

What are your priorities as Commercial Director? 

Niklas Green: My top priority is to connect more Finnish companies with the right sources of capital. There are many businesses here with genuine potential, but they struggle to access debt financing. I want to change that. To me, this is more than single transactions for companies in need of capital. I see it as a partnership. 

I want to build a network that works. That includes banks, lenders, local investors, startup hubs, business-focused organizations, and anyone who wants to support the Finnish SME sector. When we bring these players together, we can create a long-term financing ecosystem that can tap into the market opportunity in Finland. 

It is not just about large funds or institutional investors. Often, the most active investors are entrepreneurs who have built or sold businesses and are now ready to support the next generation. I want to connect them with companies that are ready to grow. That is what impact means to me—bringing together capital, knowledge, and connections to support sustainable solutions and above all create jobs where people can earn a living. That is exactly what I want to build. 

What motivates you personally, and what do you want to change? 

Niklas Green:  Technology and AI tools offer enormous potential. We should automate tasks that do not require personal consultation. This frees up time for what really matters—analyzing investment opportunities, advising investors, and closing deals. 

But for me, it’s about more than efficiency. I want to use capital in ways that create attractive returns for everyone; the investor, the company and society as a whole. In a fast-changing world, we need companies that are financially strong and socially responsible.  
 
After all the world we know and the jobs we have is created by the interaction of companies, society and investors. We need to ensure that these companies have access to capital markets because without capital companies cannot function and play their role in a socially responsible economy. The best way to do this is to take an active position in the financing of such companies. This is how we can create meaningful impact; investors earn a return, and companies obtain access to capital. With this capital companies can grow, employ workers, and ultimately have a societal impact. 

Impact Investing: You don’t just want to invest, you want to make a difference?   
Discover opportunities to invest in companies shaping the future.

Meet more of Invesdor’s employees:

From its beginnings in a back room that smelled more of coffee and new beginnings to becoming the leading platform for impact investing in Europe: Interview with Franziska Haeßler

The fascination of venture capital – about innovation, investments and big ideas:
Interview with Lukas Linn

What do chanterelles, PowerPoint presentations and personalisation have in common? About campaigns, AI trends, clear strategies and creativity: 
Interview with Maximilian von Aufschnaiter

The post Niklas Green appointed Commercial Director Nordics: Insights on the Finnish market and investor outlook first appeared on Invesdor - Blog.

The phone buzzes. Inflation hits a new high, it says. “I really need to get a better grip on my finances.” This thought often creeps in somewhere between the supermarket checkout, a push notification, and a bank balance. Suddenly, the prices in your cart feel twice as expensive. Behind you, someone is talking about bonds, investments, and returns. And on the way home, you wonder where to even begin. Terms like interest rates, sustainability, and other buzzwords swirl around you. 

The savings account is losing value, retirement plans seem shaky, and trust in old financial models is crumbling. At the same time, there’s a growing desire to use money meaningfully—not just to grow it, but to shape something with it. Investing in ideas, in the future, in responsibility. 

But how do you get started? Books open your eyes to connections, tell the stories behind the markets, and show how our thinking about money shapes our lives. They’re more than just advice. 

We’ve selected these ten books for anyone who wants to understand how money, values, and the future are interconnected. And for those who want to invest smarter, more consciously, and with greater purpose. 

Why engage with investing?

More and more people want to take responsibility – over their wealth, their future, and their values. It’s about:

• Planning ahead: State pensions are no longer enough for many. Private investments are becoming a second pillar. 
• Autonomy: When you invest, you decide what happens with your money. 
• Values: Sustainable and social investments are gaining importance. Returns alone are no longer convincing. 
• Security: In uncertain economic times, knowledge creates stability

Invesdor is a platform that offers access to investment projects that combine returns with responsibility, through crowdinvesting, equity, or convertible bonds, with transparency and impact. But how do you choose? A solid understanding of investing is key. That’s why we’ve put together a list of finance books that can help you make informed decisions in 2026 to invest and grow your money.

How the list was created 

This list isn’t based on sales figures. Each book was decided for the value it brings to you as an investor. The criteria: 

• Current topics and fresh perspectives 
• Practical relevance for real-world investment decisions 
• Clarity, even without a finance degree
• Connection to sustainable or alternative investments
• Readable and inspiring 

The 10 Best Finance Books of 2025  

1. The Big Pivot, Andrew S. Winston 

What it’s about: This book explores how companies and investors are aligning with sustainable strategies in the face of climate change, resource scarcity, and increasing transparency. It offers ten proven, practical approaches. 
 
Why we recommend it: ESG and future-proof investing are key themes for 2025 and will remain so in 2026. 
 
Who it’s for: Investors who want to take a long-term, impact-oriented approach.  
 
Link: https://amzn.eu/d/9W05B4t 

Take-away: The future is strategy. If you understand it, you invest better.

Good fit if 
You prefer sustainable investments 
You assess companies based on impact 
You think long-term

Not for you if 
You’re only after short-term gains 
You want to stick to traditional metrics 
You’re not interested in deeper strategic thinking

Better suited alternative: Thinking in Bets von Annie Duke, if you’re looking to structure decisions and risk in a more pragmatic way. 

2. Thinking in Bets, Annie Duke

What it’s about:  Poker champion Annie Duke explains how to make smarter decisions under uncertainty. Encourages rational thinking over prediction-based guesswork. 
 
Why we recommend it: Especially useful for alternative investments. 

Charles Duhigg, author of The Power of Habit and Smarter Faster Better, says: “With wonderful storytelling talent and subtle humour, Annie Duke has created the ultimate guide to dealing with risk. We can all learn to make better decisions by learning from someone who earned a living making decisions where millions were at stake.” 

Who it’s for: Anyone exploring crowdinvesting, start-ups, or other higher-risk investments. 
 
Link: https://amzn.eu/d/2vLu5pQ 

Take-away: Better decisions come from understanding, not resisting, uncertainty. 

Good fit if: 
You want to improve your decision-making 
You invest actively and manage risk 
You’re exploring alternative investments 

Not for you if: 
You prefer passive, automated strategies 
You dislike self-reflection 
You expect fast, emotional results 

Better suited alternative: The Psychology of Money von Morgan Housel, if you are looking for a more accessible introduction to behavior. 

3. The Psychology of Money, Morgan Housel

What it’s about:  Behavioral finance lessons on money, wealth, and contentment. Shows how emotions influence our investment decisions.
 
Why we recommend it: In 2025, uncertainty and distractions dominate – behavior drives returns. 
 
Tim Hale, author of Smarter Investing – Simpler Decisions for Better Results, says: “Morgan Housel’s new book uses razor-sharp and accessible insights to illustrate that building wealth is a matter of mindset, not investment. This is the first book every investor should read.” 
 
Who it’s for: Beginners and professionals who want to sharpen their thinking about money. 
 
Link: https://amzn.eu/d/7G2RDni 

Take-away:  Financial intelligence is less about knowledge and more about behavior. 

Good fit if: 
You want to understand and improve your mindset 
You invest calmly and with a long view 
You appreciate storytelling and examples 

Not for you if: 
You expect technical strategies and formulas 
You only want finance jargon 
You don’t plan on reflecting 

Better suited alternative: Adaptive Markets von Andrew W. Lo, if you prefer an analytical theoretical perspective on markets. 

4. Quit, Annie Duke

What it’s about:  How to know when to walk away from a decision. Duke shows that quitting at the right time is smarter than persisting at all costs. 
 
Why we recommend it: Risk management is crucial in 2025, especially in VC and crowdinvesting. 
 
Who it’s for: Investors who want to consciously define exit criteria. 
 
Link:  https://amzn.eu/d/5YK5dUe 

Take-away: Success comes when you let go at the right time. 

Good fit if: 
You actively manage investments and risks 
You want to detect mistakes early 
You make decisions analytically 

Not for you if: 
You stubbornly stick to plans 
You rely on gut feeling 
You dislike questioning strategies 

Better suited alternative: Thinking in Bets, to first build a stronger decision-making foundation. 

5. The Business of Venture Capital, Mahendra Ramaswamy  

What it’s about: Guide to establishing and managing venture capital funds, including fundraising, investment structure, portfolio development, value creation, and exit strategies. With checklists, case studies, and practical expertise from experts. 

Why we recommend it: Venture capital remains a key area within alternative investments. This book offers strategic insights and practical tools straight from the source, valuable for investors as well.
 
Who it’s for: Aspiring and experienced VC professionals, fund founders, business angels, limited partners, start-up investors, and MBA students. 
 
Link: https://amzn.eu/d/4zdvLzC  

Take-away: Those who understand how venture capital works invest more successfully in the long term. 

Good fit if: 
You want to invest in start-ups or companies 
You want to understand deal structures 
You see equity as a strategy 

Not for you if: 
You don’t have time for technical topics 
You prefer narrative-driven books 
You stick to very simple products 

Better suited alternative: Richer, Wiser, Happier by William Green, if you would rather understand investments through the personal principles and experiential knowledge of successful investors. 

6. The End of ESG, Phil Gramm and Terrence Keeley

What it’s about:  A critical analysis of why ESG needs reform and how impact investing can be made more effective.
 
Why we recommend it: Der ESG-Diskurs prägt 2025 Anlagepolitik, Regulierung und Produkte. Dieses Buch ordnet ein und öffnet Perspektiven. 
 
Who it’s for: The ESG discourse is shaping investment policy, regulation, and products in 2025. This book provides context and opens up new perspectives.
 
Link : https://amzn.eu/d/2v80Uek 

Take-away: Sustainability needs clear goals and measurable impact.

Good fit if: 
You want to truly understand ESG 
You structure portfolios based on impact 
You’re open to critical debates 

Not for you if: 
You’re just looking to validate your ESG routines 
You’re not interested in methodology 
You chase returns without considering impact  

Better suited alternative: The Big Pivot, if you want to see sustainability in a more practical way in everyday business life. 

7. How Big Things Get Done, Bent Flyvbjerg

What it’s about:  Success principles for projects big and small, from mega ventures to start-ups, from Olympic stadiums to kitchen renovations. With clear, data-driven strategies for delivering projects on time, on budget, and with realistic expectations. 
 
Why we recommend it: Whether it’s real estate, infrastructure, or a start-up: project competence determines returns. This book delivers the formula for success, scientifically grounded and highly practical.
 
Who it’s for: Investors, project managers,
entrepreneurs and anyone who wants to plan and implement ambitious projects more effectively. 
 
Link:  https://amzn.eu/d/828Uyin 

Take-away: Good projects result from good planning and realistic risk management.  

Good fit if: 
You want to understand project logic 
You’re evaluating real estate or infrastructure investments 
You value practical case studies 

Not for you if: 
You’re not interested in real-world project applications 
You only read about capital markets 
You prefer theory without case studies 

Better suited alternative: Adaptive Markets, for more market model focus over project practice.  

8. Adaptive Markets, Andrew W. Lo

What it’s about:  A new market model that combines classical financial theory with insights from psychology, neurobiology, AI, and behavioral economics. Lo shows that markets are not stable systems, they evolve. And so does investor behavior.

Why we recommend it: In times of innovation, AI, and crises, this book offers a deep understanding of how markets truly function, beyond black-and-white thinking between “rational” and “irrational.”
 
Who it’s for: Advanced investors, financial professionals and interested parties who want to gain a deeper understanding of theories and market dynamics. 
 
Link: https://amzn.eu/d/9bSYCDa 

Take-away: Markets are adaptive. Those who understand their dynamics can spot opportunities and avoid poor decisions.

Good fit if: 
You want to link theory with practice 
You want a structured view on market dynamics 
You enjoy analytical reading 

Not for you if: 
You want a narrative, beginner-friendly entry point 
You dislike models and formulas 
You want quick, practical tips 

Better suited alternative: The Psychology of Money, for a behavioral view without the theoretical burden. 

9. What We Owe the Future, William MacAskill

What it’s about: A philosophical case for “longtermism” – the idea that our actions today fundamentally shape the quality of life for future generations. MacAskill shows how we can take ethical, political, and technological responsibility for a livable future.
 
Why we recommend it: Sustainability doesn’t end with CO₂ emissions. This book broadens the perspective and offers an ethical framework for long-term thinking, also in the context of investing, technology, and societal development.
 
Who it’s for: For anyone who wants to meaningfully connect ethical responsibility, future-oriented thinking, and capital, whether as an investor, entrepreneur, or citizen.
 
Link: https://amzn.eu/d/3niocq2 

Take-away: Capital shapes the future. But only long-term responsibility secures it.

Good fit if: 
You think long-term 
You integrate values into investment decisions 
You want to measure impact 

Not for you if: 
You only chase short-term metrics 
You want to separate ethics from investing 
You expect product comparisons 

Better suited alternative:The Big Pivot von Andrew S. Winston, if you prefer to view long-term responsibility in terms of concrete, business-oriented strategies and corporate practices.

10. Richer, Wiser, Happier, William Green 

What it’s about:  Conversations with successful investors.
This book offers insights into the mindset of legendary investors – from Sir John Templeton to Charlie Munger, ETF pioneer Jack Bogle to mathematician Ed Thorp, Will Danoff to globally focused Laura Geritz, Indian value investor Mohnish Pabrai to Joel Greenblatt and Howard Marks, whose memos Warren Buffett never missed. It reveals what drives their success and offers inspiration that goes far beyond money.
 
Why we recommend it: Learning curves from real-life biographies are both applicable and motivating.
 
Who it’s for: Anyone who wants to learn from best practice. 
 
Link: https://amzn.eu/d/eItx6yh 

Take-away: There are many paths to success. What matters are your own principles. 

Good fit if: 
You’re seeking tested mindsets and behaviors 
You value real-world stories 
You want to refine your own investing playbook 

Not for you if: 
You only want hard theory and formulas 
You expect step-by-step instructions 
You prefer impersonal case studies 

Better suited alternative: The Business of Venture Capital—if you want to dive deep into formal equity structures. 

Conclusion: Knowledge is the most reliable investment  

These books don’t replace financial advice, but they expand your perspective. They help you understand markets, avoid thinking traps, and act with clarity. 

Whether you’re just starting out or growing your portfolio: a good book is often the first step to better decisions. 

Read mindfully. Think forward. Invest the way you want to live: consciously, informed, and with impact. 

FAQ – Frequently asked questions about financial books 

Invesdor – Investing with impact. 
Crowd investing, bonds, equity. 
Knowledge builds trust. Trust builds the future.

The post Understand more, invest better: the 10 best finance books for 2026  first appeared on Invesdor - Blog.